Skip to main content
Clinical Trials/NCT02920034
NCT02920034
Completed
Not Applicable

A Randomized Comparison of Ultrasound Based Versus Radiofrequency Based Catheter Ablation Techniques in Patients With Therapy Resistant Arterial Hypertension With Large Renal Arteries

Heart Center Leipzig - University Hospital1 site in 1 country120 target enrollmentJune 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Therapy Resistant Hypertension
Sponsor
Heart Center Leipzig - University Hospital
Enrollment
120
Locations
1
Primary Endpoint
Daytime blood pressure change
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Prospective, randomized trial to assess the effectiveness of different renal sympathetic denervation methods (radiofrequency main vs. branches + main vs. ultrasound based) in a cohort of patients with therapy refractory arterial hypertension and large renal arteries

Detailed Description

The aim of this trial is a prospective, randomized comparison of three different techniques for catheter based renal sympathetic denervation. Patients with larger (\>5.5 mm) renal arteries are randomized to a treatment with a radiofrequency based catheter of the main renal artery, the main renal artery, its side-branches and accessories or an ultrasound-based denervation of the main renal artery only. The primary endpoint is the change in daytime blood pressure acquired in ambulatory blood pressure measurement at 3 months.

Registry
clinicaltrials.gov
Start Date
June 2015
End Date
June 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Heart Center Leipzig - University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Philipp Lurz

Clinical Investigator, Professor, Managing Senior Physician

Heart Center Leipzig - University Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients with resistant hypertension (≥3 antihypertensive drugs including at least one diuretic, without any dosage change in the preceding 4 weeks) and a systolic office blood pressure of \>160 mmHg, ≥1 main renal artery diameter \>5.5 mm

Exclusion Criteria

  • pregnancy, known renal artery stenosis, average systolic daytime RR \<135 mmHg in 24h ambulatory blood pressure measurement (ABPM), ≥1 renal artery diameter \<4.0 mm, life-expectancy \<6 months, participation in any other clinical trial.

Outcomes

Primary Outcomes

Daytime blood pressure change

Time Frame: 3 months after Intervention

Daytime blood pressure change in ambulatory blood pressure measurement

Secondary Outcomes

  • General blood pressure change(24 months after Intervention)
  • Daytime blood pressure change(24 months after Intervention)
  • Exercise blood pressure change(3 months after Intervention)

Study Sites (1)

Loading locations...

Similar Trials